Novel Surgical Procedures for Treatment-Resistant MDD, OCD
In the last year, statistics estimate that 1% to 2% of adults experience obsessive-compulsive disorder (OCD) and 10% of adults suffer from major depressive disorder (MDD) in the United States. Many of these individuals are classified as treatment-resistant since they do not respond to pharmacologic therapy and psychotherapy. Researchers recently announced the use of three surgical procedures for these patients. Read more.

Early Identification, Clinical Intervention Vital for MDD
A recent study published in the Journal of the American Medical Association indicated that among those with major depressive disorder (MDD), the elevated disease burden of treatment-resistant depression (TRD) on the patient and healthcare system may be diminished by early recognition and intervention. Find out more on the effects of long duration from MDD diagnosis until TRD.

Clinical Guideline Updated for MDD Acute Phase
The American College of Physicians recently published its updated guideline regarding clinical recommendations for nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder (MDD). The guideline emphasizes the importance of tailoring therapy to patient needs and the significance of shared decision-making between clinician and patient to improve adherence and clinical outcomes. Read more.